Literature DB >> 3357211

Standardized and simplified nomenclature for proteins common to all retroviruses.

J Leis1, D Baltimore, J M Bishop, J Coffin, E Fleissner, S P Goff, S Oroszlan, H Robinson, A M Skalka, H M Temin.   

Abstract

We propose a revised standardized nomenclature for the proteins common to all retroviruses on the basis of biological function, enzymatic activity, and/or virion location data. (We do not discuss proteins specific for subfamilies or only some retroviruses.)

Mesh：

Substances：

Year:  1988        PMID： 3357211      PMCID： PMC253234     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  6 in total

1.  Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus.

Authors:  K Rushlow; K Olsen; G Stiegler; S L Payne; R C Montelaro; C J Issel
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

2.  Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus.

Authors:  P Sonigo; C Barker; E Hunter; S Wain-Hobson
Journal:  Cell       Date:  1986-05-09       Impact factor: 41.582

3.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

Authors:  J T August; D P Bolognesi; E Fleissner; R V Gilden; R C Nowinski
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

4.  Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.

Authors:  L E Henderson; R C Sowder; G W Smythers; S Oroszlan
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.

Authors:  R M Stephens; J W Casey; N R Rice
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

6.  Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus.

Authors:  L E Henderson; R Sowder; G Smythers; R E Benveniste; S Oroszlan
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103
  6 in total
  141 in total

1.  The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage.

Authors:  Steven C Pettit; Sergei Gulnik; Lori Everitt; Andrew H Kaplan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  A long terminal repeat-containing retrotransposon of Schizosaccharomyces pombe expresses a Gag-like protein that assembles into virus-like particles which mediate reverse transcription.

Authors:  Laure Teysset; Van-Dinh Dang; Min Kyung Kim; Henry L Levin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.

Authors:  E C Jørgensen; F S Pedersen; P Jørgensen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Complementation studies with Rous sarcoma virus gag and gag-pol polyprotein mutants.

Authors:  S Oertle; N Bowles; P F Spahr
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV.

Authors:  C Roy; N Tounekti; M Mougel; J L Darlix; C Paoletti; C Ehresmann; B Ehresmann; J Paoletti
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

6.  Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.

Authors:  D P Burns; R C Desrosiers
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.

Authors:  M Katzman; R A Katz; A M Skalka; J Leis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.

Authors:  J Konvalinka; M A Litterst; R Welker; H Kottler; F Rippmann; A M Heuser; H G Kräusslich
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.